Phase III Clinical Trial Comparing the Efficacy and Safety of DA-3803(Recombinant Human Chorionic Gonadotrophin) and Ovidrel for Inducting Final Follicular Maturation and Early Luteinization in Women Undergoing Ovulation
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Choriogonadotropin alfa (Primary)
- Indications Female infertility
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Dong-A ST
- 23 Nov 2012 New trial record